Home > Products > Tumor Cell Lines > Animal Tumor Cell Lines >
FRTL-5 |
||||
---|---|---|---|---|
Product Name |
FRTL-5 |
|||
Price | Get Quote | |||
Product Code | FRTL 5; FRTL5; FRTL-5 Cl 2 |
|||
Cat.No |
ABC-TC0257 |
Species |
Rattus Norvegicus |
|
Size/Quantity |
1 vial |
Biosafety Level |
1 |
|
Shipping Info |
Dry Ice |
Storage |
Liquid Nitrogen |
|
Description |
Why choose FRTL-5 from AcceGen? FRTL-5 cells from AcceGen exhibit exceptional features, including high viability and quality, as they are meticulously incubated under optimal conditions. These cells undergo daily status monitoring to guarantee the absence of bacteria and fungi. Rigorous quality control measures, including PCR-based assays to confirm the absence of mycoplasma contamination and identity verification through STR analysis, ensure the reliability and purity of this cell line. |
|||
Citation Guide |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). |
|||
Application | FOR RESEARCH USE ONLY The FRTL-5 cell line serves as a distinctive model for investigating thyroid cell behavior and has found versatile applications. These cells are utilized as assays to quantify the stimulatory activity of autoimmune immunoglobulins in Graves’ disease patients, offering insights into the multifaceted functionality of thyroid receptor antibodies (TRAbs) in this context. Researchers depend on FRTL-5 cells to delve into the inner workings of thyroid cells, exploring hormone dependency and secretion mechanisms. Their capacity to maintain the characteristics of differentiated thyroid cells makes them a crucial platform for dissecting the intricate processes governing thyroid function. |
|||
Growth Conditions | 37 ℃, 5% CO2 |
|||
Product Type |
Rat Thyroid Cell Lines |
|||
Product Image |
![]() |
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.